{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:38:43Z","timestamp":1788349123376,"version":"build-2803163510"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Effective oral medication for use in men with Peyronie's disease (PD) has been an area of interest of the medical community and lay public for decades. Isolated septal scars (ISS) without evidence of penile deformity is a relatively new clinical entity, and at present, there is paucity in the published literature regarding its treatment. Current research into the use of phosphodiesterase type 5 (PDE5) inhibitors in regulating penile erectile response has revealed an alternative role for PDE5 inhibitors in decreasing oxidative stress-associated inflammatory change as seen in PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To examine the presence of ISS and assess the efficacy of PDE5 inhibitor use in septal scar remodeling.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Retrospective review of prospective database on all men who underwent penile Doppler ultrasound between December 2007 and December 2009.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Of the 65 men with ultrasonographic-confirmed ISS, 35 men received tadalafil 2.5\u2009mg daily over a 6-month period. The clinical outcomes between the two groups were compared using International Index of Erectile Function (IIEF)-5 score and 6 months penile Doppler ultrasound follow up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The mean age for the tadalafil group was 43.2 (20\u201365) years, similar to the control group at 44.2 (34\u201372) years. The length of time from onset to presentation was 22 (6 to 40) months. The majority of ultrasonographic-proven ISS was not clinically palpable and complaint of decreased penile rigidity (66%) was the predominant feature. Treatment with low-dose daily tadalafil did not result in any significant side effects (such as headache and flushing) or discontinuation. The tadalafil group reported higher IIEF-5 score (pretreatment 11\/25 to post-treatment 18\/25) (P \u2009&amp;lt;\u20090.01) and resolution of septal scar were recorded in 24 patients (69%) compared to three patients (10%) in the control group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Low-dose daily tadalafil is a safe and effective treatment option in septal scar remodeling.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02217.x","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T21:34:47Z","timestamp":1297892087000},"page":"1472-1477","source":"Crossref","is-referenced-by-count":81,"title":["The Role of PDE5 Inhibitors in Penile Septal Scar Remodeling: Assessment of Clinical and Radiological Outcomes"],"prefix":"10.1093","volume":"8","author":[{"given":"Eric","family":"Chung","sequence":"first","affiliation":[{"name":"Division of Urology, St Joseph Health Care , London, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"DeYoung","sequence":"additional","affiliation":[{"name":"Division of Urology, St Joseph Health Care , London, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald B.","family":"Brock","sequence":"additional","affiliation":[{"name":"Division of Urology, St Joseph Health Care , London, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,5,1]]},"reference":[{"key":"2024032521503597700_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1743-6109.2004.10116.x","article-title":"Peyronie's disease","volume":"1","author":"Pryor","year":"2004","journal-title":"J Sex Med"},{"key":"2024032521503597700_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2605.2005.00587.x","article-title":"Diagnosing erectile dysfunction: The penile dynamic duplex ultrasound revisited","volume":"28","author":"Aversa","year":"2005","journal-title":"Int J Androl"},{"key":"2024032521503597700_bb0020","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1111\/j.1743-6109.2009.01438.x","article-title":"Penile sonographic and clinical characteristics in men with Peyronie's disease","volume":"6","author":"Smith","year":"2009","journal-title":"J Sex Med"},{"key":"2024032521503597700_bb0025","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.juro.2009.12.026","article-title":"Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?","volume":"183","author":"Breyer","year":"2010","journal-title":"J Urol"},{"key":"2024032521503597700_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.juro.2006.08.065","article-title":"Isolated septal fibrosis or hematoma-atypical Pyeronie's disease?","volume":"177","author":"Brant","year":"2007","journal-title":"J Urol"},{"key":"2024032521503597700_bb0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5347(17)49862-4","article-title":"Peyronie's disease: An unusual location","volume":"132","author":"Szollar","year":"1984","journal-title":"J Urol"},{"key":"2024032521503597700_bb0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1743-6109.2006.00316.x","article-title":"Nonpalpable scarring of the penile septum as a cause of erectile dysfunction: An atypical form of Peyronie's disease","volume":"4","author":"Bella","year":"2007","journal-title":"J Sex Med"},{"key":"2024032521503597700_bb0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1464-410X.2006.05955.x","article-title":"Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease","volume":"97","author":"Ferrini","year":"2006","journal-title":"BJU Int"},{"key":"2024032521503597700_bb0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1464-410X.2007.07223.x","article-title":"Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection","volume":"101","author":"Kovanecz","year":"2008","journal-title":"BJU Int"},{"key":"2024032521503597700_bb0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.ijir.3901612","article-title":"Long-term continuous sildenafil treatment ameriolates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats","volume":"20","author":"Kovanecz","year":"2008","journal-title":"Int J Impot Res"},{"key":"2024032521503597700_bb0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.ju.0000106970.97082.61","article-title":"Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy","volume":"171","author":"Schwartz","year":"2004","journal-title":"J Urol"},{"key":"2024032521503597700_bb0065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ajcp\/45.6.670","article-title":"Peyronie's disease","volume":"45","author":"Smith","year":"1966","journal-title":"Am J Clin Pathol"},{"key":"2024032521503597700_bb0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-5347(01)65359-X","article-title":"The anatomy of the tunica albuginea in the normal penis and Peyronie's disease","volume":"157","author":"Brock","year":"1997","journal-title":"J Urol"},{"key":"2024032521503597700_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1743-6109.2008.01195.x","article-title":"Mechanisms of penile fibrosis","volume":"6","author":"Gonzalez-Cadavid","year":"2009","journal-title":"J Sex Med"},{"key":"2024032521503597700_bb0080","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2007.07.013","article-title":"The natural history of Peyronie's disease: An ultrasonography-based study","volume":"53","author":"Bekos","year":"2008","journal-title":"Eur Urol"},{"key":"2024032521503597700_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02924008","article-title":"Duplex ultrasound findings in men with Peyronie's disease","volume":"12","author":"Lopez","year":"1991","journal-title":"Urol Radiol"},{"key":"2024032521503597700_bb0090","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0022-5347(01)68236-3","article-title":"An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"key":"2024032521503597700_bb0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","article-title":"L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures","volume":"9","author":"Valente","year":"2003","journal-title":"Nitric Oxide"},{"key":"2024032521503597700_bb0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1089-8603(02)00124-6","article-title":"Effect of nitric oxide on the differentiation of fibroblast into myofibroblast in the Peyronie's fibrotic plaque and in its rat model","volume":"7","author":"Vernet","year":"2002","journal-title":"Nitric Oxide"},{"key":"2024032521503597700_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/B:HREV.0000011394.34355.bb","article-title":"Matrix metalloproteinases: Pathways of induction by bioactive molecules","volume":"9","author":"Tsuruda","year":"2004","journal-title":"Heart Fail Rev"},{"key":"2024032521503597700_bb0110","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1743-6109.2010.01790.x","article-title":"Pentoxifylline attenuates transforming growth factor-\u03b21-stimulated collagen deposition and elastogenesis in human tunica albuginea derived fibroblasts part 1: Impact on extracellular matrix","volume":"7","author":"Shindel","year":"2010","journal-title":"J Sex Med"},{"key":"2024032521503597700_bb0115","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515335049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515335049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/5\/1472\/47245343\/jsm_8_5_1472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/5\/1472\/47245343\/jsm_8_5_1472.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:01:54Z","timestamp":1711404114000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/8\/5\/1472\/6843955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,1]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5,1]]},"published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02217.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,5]]},"published":{"date-parts":[[2011,5,1]]}}}